A group of researchers from the National University of Singapore and National Centre for Infectious Diseases studied the detailed role of aerosol particles in the transmission of SARS-CoV-2.
The group was led by the Duke NUS Medical School in Singapore.
Coarse and fine particles were examined separately with reverse-transcriptase quantitative PCR (RT-qPCR), using a positive control plasmid to set a standard curve for viral RNA particles. With this approach, the team detected SARS-CoV-2 in samples from 13 patients, including both asymptomatic and pre-symptomatic participants.
They also found that participants who had been infected for less time were more likely to exhale higher levels of SARS-CoV-2 RNA. Patients who emitted the most viral load did so on Day 3 of their illness. Importantly, the majority of the RNA copies detected in this experiment (85.4%) came from fine particles rather than coarse ones, and overall, more RNA was released when participants were talking and singing, compared to simply breathing.
The team used a Gesundheit II (G-II) machine to measure the viral loads in respiratory aerosols emitted by COVID-19 patients. The G-II breath collector enabled the researchers to capture viral RNA in both fine (≤ 5 μm) and coarse (> 5 μm) respiratory aerosols emitted by 22 patients while they breathed normally, talked, and sang into the device at timed intervals.
Participants were asked to repeat passages of a children’s book and sing common American children’s songs. By drawing air from around the patient’s head into the machine throughout the testing period, exhaled particles were pulled into the sampling environment rather than dissipating into the room.
Though the researchers were not able to successfully culture the virus, this study provides important information as to the role that fine aerosols play in SARS-CoV-2 transmission. They also note that only one study participant was found to be infected with the highly transmissible SARS-CoV-2 Delta variant, thus more research is urgently needed to study Delta and other emerging variants.